Paris: Sanofi has announced that the European Medicines Agency (EMA)'s Committee for Medicinal Products for Human Use (CHMP) ...

EMA committee recommends approval of Bristol Myers’ repotrectinib to treat advanced ROS1-positive NSCLC & NTRK-positive solid tumours: Princeton, New Jersey Monday, November 18, ...

The IOC has established a zero-tolerance policy to combat cheating and hold accountable anyone responsible for using or providing doping products. The organisation’s efforts are focused on prevention ...